Efficacy and safety in the treatment of hyperprolactinemia: A systematic review and network meta-analysis.
Mariana Millan FachiLays de Deus BuenoDenise Colaço de OliveiraLetícia Lazarin da SilvaAline F BonettiPublished in: Journal of clinical pharmacy and therapeutics (2021)
This is the first network meta-analysis that evaluated the efficacy and safety of dopaminergic agonists in the treatment of hyperprolactinemia. The results of this review revealed that these drugs have similar efficacy, but cabergoline has a better safety profile.